Heparan Sulfate in the Tumor Microenvironment

被引:22
作者
Bartolini, Barbara [1 ]
Carava, Elena [1 ]
Caon, Ilaria [1 ]
Parnigoni, Arianna [1 ]
Moretto, Paola [1 ]
Passi, Alberto [1 ]
Vigetti, Davide [1 ]
Viola, Manuela [1 ]
Karousou, Evgenia [1 ]
机构
[1] Univ Insubria, Dept Med & Surg, Varese, Italy
来源
TUMOR MICROENVIRONMENT: EXTRACELLULAR MATRIX COMPONENTS - PT A | 2020年 / 1245卷
关键词
Heparan sulfate; Tumor; Glycosaminoglycan; Proteoglycan; UDP-sugars; Heparanase; Extracellular matrix; Cancer; Cell growth; Invasion; Adhesion; Metastasis; Inflammation; Angiogenesis; Growth factor; FIBROBLAST-GROWTH-FACTOR; MAMMALIAN HEPARANASE; COLLAGEN-XVIII; MANNOSE; 6-PHOSPHATE; CANCER METASTASIS; FACTOR-BINDING; CELL-ADHESION; BREAST-CANCER; PROTEOGLYCANS; EXPRESSION;
D O I
10.1007/978-3-030-40146-7_7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The biology of tumor cells strictly depends on their microenvironment architecture and -composition, which controls the availability of growth factors and signaling molecules. Thus, the network of glycosaminoglycans, proteoglycans, and proteins known as extracellular matrix (ECM) that surrounds the cells plays a central role in the regulation of tumor fate. Heparan sulfate (HS) and heparan sulfate proteoglycans (HSPGs) are highly versatile ECM components that bind and regulate the activity of growth factors, cell membrane receptors, and other ECM molecules. These HS binding partners modulate cell adhesion, motility, and proliferation that are processes altered during tumor progression. Modification in the expression and activity of HS, HSPGs, and the respective metabolic enzymes results unavoidably in alteration of tumor cell microenvironment. In this light, the targeting of HS structure and metabolism is potentially a new tool in the treatment of different cancer types.
引用
收藏
页码:147 / 161
页数:15
相关论文
共 128 条
[51]  
Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738
[52]   Recent advances in the discovery of heparanase inhibitors as anticancer agents [J].
Jia, Li ;
Ma, Shutao .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 121 :209-220
[53]   Perlecan and tumor angiogenesis [J].
Jiang, XN ;
Couchman, JR .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2003, 51 (11) :1393-1410
[54]   Interaction of chemokines and glycosaminoglycans: A new twist in the regulation of chemokine function with opportunities for therapeutic intervention [J].
Johnson, Z ;
Proudfoot, AE ;
Handel, TM .
CYTOKINE & GROWTH FACTOR REVIEWS, 2005, 16 (06) :625-636
[55]   Matrix modeling and remodeling: A biological interplay regulating tissue homeostasis and diseases [J].
Karamanos, Nikos K. ;
Theocharis, Achilleas D. ;
Neill, Thomas ;
Iozzo, Renato V. .
MATRIX BIOLOGY, 2019, 75-76 :1-11
[56]   Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics [J].
Kararnanos, Nikos K. ;
Piperigkou, Zoi ;
Theocharis, Achilleas D. ;
Watanabe, Hideto ;
Franchi, Marco ;
Baud, Stephanie ;
Brezillon, Stephane ;
Goette, Martin ;
Passi, Alberto ;
Vigetti, Davide ;
Ricard-Blum, Sylvie ;
Sanderson, Ralph D. ;
Neill, Thomas ;
Iozzo, Renato V. .
CHEMICAL REVIEWS, 2018, 118 (18) :9152-9232
[57]   Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer [J].
Karousou, Evgenia ;
Misra, Suniti ;
Ghatak, Shibnath ;
Dobra, Katalin ;
Goette, Martin ;
Vigetti, Davide ;
Passi, Alberto ;
Karamanos, Nikos K. ;
Skandalis, Spyros S. .
MATRIX BIOLOGY, 2017, 59 :3-22
[58]   Collagen XVIII, a basement membrane heparan sulfate proteoglycan, interacts with L-selectin and monocyte chemoattractant protein-1 [J].
Kawashima, H ;
Watanabe, N ;
Hirose, M ;
Sun, X ;
Atarashi, K ;
Kimura, T ;
Shikata, K ;
Matsuda, M ;
Ogawa, D ;
Hejasvaara, R ;
Rehn, M ;
Pihlajaniemi, T ;
Miyasaka, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (15) :13069-13076
[59]   Syndecan-1 Is Required for Robust Growth, Vascularization, and Metastasis of Myeloma Tumors in Vivo [J].
Khotskaya, Yekaterina B. ;
Dai, Yuemeng ;
Ritchie, Joseph P. ;
MacLeod, Veronica ;
Yang, Yang ;
Zinn, Kurt ;
Sanderson, Ralph D. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (38) :26085-26095
[60]  
Kisker O, 2001, CANCER RES, V61, P7669